Moreover, while pathways such as IGF-1/Akt/mTOR, myostatin signaling, and inflammatory cascades have been characterized, controversies persist regarding the relative weight of each in different conditions (e.g., sarcopenia vs. cachexia). The gene discussed is MTOR; the disease is sarcopenia.